← Ireland

S.I. No. 116/2000 - Medicinal Products (Prescription and Control of Supply) (Amendment) Regulations, 2000

S.I. No. 116/2000 - Medicinal Products (Prescription and Control of Supply) (Amendment) Regulations, 2000 Skip to content Disclaimer Feedback Helpdesk Gaeilge Léim go dtí an t-ábhar Séanadh Aiseolas Deasc chabhrach English Gaeilge English Produced by the Office of the Attorney General Táirgthe ag Oifig an Ard-Aighne Home Legislation Acts of the Oireachtas Statutory Instruments Pre-1922 Legislation Constitution External Resources Bills (Houses of the Oireachtas) Iris Oifigiúil / Official Gazette Revised Acts (LRC) Classified List of Legislation (LRC) Translations (acts.

  1. ie)Translations (Houses of the Oireachtas) Government Publications for Sale EU Law (EUR-Lex) FAQ Disclaimer Feedback Helpdesk Search Baile Reachtaíocht Achtanna an Oireachtais Ionstraimí Reachtúla Reachtaíocht Réamh-1922 Bunreacht Acmhainní Seachtracha Billí (Tithe an Oireachtais) Iris Oifigiúil Achtanna Athbhreithnithe (CAD) (An Coimisiún um Athchóiriú an Dlí) Liosta Rangaithe Reachtaíochta Aistriúcháin (achtanna.
  2. ie)Aistriúcháin (Tithe an Oireachtais) Foilseacháin Rialtais ar Díol Dlí AE (EUR-Lex) CCanna (Ceisteanna Coitianta) Séanadh Aiseolas Deasc chabhrach Cuardach TitleTeideal Year(
  3. s)or rangeBliain nó blianta nó raon TypeCineál All Legislation Acts Statutory Instruments Advanced SearchCuardach Casta HomeBaile Statutory InstrumentsIonstraimí Reachtúla 2000 S.I. No. 116/2000 - Medicinal Products (Prescription and Control of Supply) (Amendment) Regulations, 2000 S.I. No. 116/2000 - Medicinal Products (Prescription and Control of Supply) (Amendment) Regulations, 2000 AmendmentsLeasuithe I, Micheal Martin, Minister for Health and Children, in exercise of the powers conferred on me by section 32 of the Irish Medicines Board Act, 1995 (No. 29 of 1995), as adapted by the Health (Alteration of Name of Department and Title of Minister) Order, 1997 ( S.I. No. 308 of 1997 ), hereby make the following Regulations- 1. These Regulations may be cited as the Medicinal Products (Prescription and Control of Supply) (Amendment) Regulations, 2000. 2. These Regulations shall be construed as one with the Medicinal Products (Prescription and Control of Supply) Regulations, 1996 to 1999 and may be cited together with those Regulations as the Medicinal Products (Prescription and Control of Supply) Regulations, 1996 to 2000. 3. The Medicinal Products (Prescription and Control of Supply) Regulations, 1996 ( S.I. No. 256 of 1996 ), as amended by the Medicinal Products (Prescription and Control of Supply) (Amendment) Regulations, 1996 ( S.I. No. 309 of 1996 ) and by the Medicinal Products (Prescription and Control of Supply) (Amendment) Regulations, 1999 ( S.I. No. 271 of 1999 ), are hereby amended by the substitution in the First Schedule thereto, for the entries in Columns 2, 3, 4 and 5 in respect of the substance specified in Column 1 of the Schedule to these Regulations, of the entries in Columns 2, 3, 4 and 5 of the Schedule to these Regulations. Schedule Substances which when contained in medicinal products are subject to prescription control and circumstances excluding certain products from such control Circumstances excluding medicinal products from prescription control Column Column Column Column Column 1 2 3 4 5 Substance Part in Schedule Maximum strength, pack size or period of treatment Use, pharmaceutical form or manner of administration Maximum dose and maximum daily dose Hydrocortisone acetate A

(1)Equivalent to 1.0% of Hydrocortisone (MS)
(1)External: For use in irritant dermatitis, contact allergic dermatitis, insect bite reactions and mild to moderate eczema. 15.0g (MPS) For use in adults and children not under 10 years.
(2)Equivalent to 1.0% of Hydrocortisone (MS) 15.0g (MPS)
(2)External: In ointments when in combination with one or more of the following: Benzyl Benzoate, Bismuth Oxide, Bismuth Subgalate, Peru Balsam, Pramoxine Hydrochloride, Zinc Oxide, for use in haemorrhoids. For use in adults and children not under 10 years.
(3)10mg (MS) 12 (MPS)
(3)External: In suppositories when in combination with one or more of the following: Benzyl Benzoate, Bismuth Oxide, Bismuth Subgalate, Peru Balsam, Pramoxine Hydrochloride, Zinc Oxide, for use in haemorrhoids. For use in adults and children not under 10 years. GIVEN under my Official Seal this 3rd day of May, 2000 Micheal Martin, T.D., _______________________ Minister for Health and Children Explanatory Note (This is not part of the instrument and does not purport to be a legal interpretation) The purpose of these Regulations is to de-regulate from prescription-only control certain ointments containing hydrocortisone acetate when intended for use in haemorrhoids. Privacy Statement Accessibility European Legislation Identifier (PDF) Open Data License Ráiteas Príobháideachais Inrochtaineacht Aitheantóir Eorpach Reachtaíochta (ELI) Ceadúnas Sonraí Oscailte Liosta Fianán © Government of Ireland. Oireachtas Copyright Material is reproduced with the permission of the Houses of the Oireachtas © Rialtas na hÉireann. Atáirgtear ábhar faoi Chóipcheart le cead ó Thithe an Oireachtais

🔗 To official source

AI explanation based on the official legal text. Indicative, not a substitute for legal advice.